NationalBharat Biotech Must Address WHO's Covaxin Suspension To Avoid EUL Cancellation, Says MEABY Outlook Web Desk
NationalCovid Vaccine Covaxin Cleared For 6-12 Age Group By Drugs Regulator DCGI: ReportsBY Outlook Web Desk
NationalSII To Give Free Covishield Vials To Pvt Vaccination Centres To Compensate For Price DifferenceBY Outlook Web Desk
NationalCOVID Vaccine Precaution Dose: Serum Institute, Bharat Biotech Cut Prices To Rs 225BY Outlook Web Desk
NationalCovaxin Booster Enhances Antibody Response Against COVID-19 Variants Including Omicron: StudyBY Outlook Web Desk
NationalIntranasal Booster Doses Against Covid-19 Are Easy To Administer | What Are These?BY Outlook Web Desk
NationalBharat Biotech's Intranasal Booster Dose Gets DCGI's Approval For Phase-3 TrialsBY Outlook Web Desk
NationalCovid-19 Vaccine For Teenagers: DCGI Grants Emergency Authorisation To CovaxinBY Outlook Web Desk
BusinessThe Jab Of Life: Covaxin’s Success Proves Bharat Biotech Was On Right PathBY Outlook Web Desk
NationalCovaxin Gets WHO Nod For Emergency Use: What That Means For Indian TravelersBY Outlook Web Desk
NationalCovaxin: WHO Panel Recommends Emergency Use Listing Status For Bharat Biotech's Covid VaccineBY Outlook Web Desk
NationalCovaxin: Bharat Biotech's Covid-19 Shot Gets Shelf Life Extension Up To 12 MonthsBY Outlook Web Desk
NationalAustralia Recognises Covaxin: All Countries That Have Approved Bharat Biotech's Covid-19 VaccineBY Outlook Web Desk
NationalCovaxin: 7 Countries Allowing Entry To Indians Vaccinated With Bharat Biotech's Covid-19 ShotBY Outlook Web Desk
Making A DifferenceCovid-19 Vaccine: Oman Approves Bharat Biotech's Covaxin Under New Travel RulesBY Outlook Web Desk
NationalWHO Technical Group To Meet On Oct 26 To Consider EUL Of Bharat Biotech’s CovaxinBY Outlook Web Desk